Julian Symons

Chief Tech/Sci/R&D Officer at ALIGOS THERAPEUTICS, INC.

Net worth: 205 756 $ as of 2026-08-30

65 year

Health Technology

Consumer Services

Profile

Julian A. Symons is Chief Scientific Officer & Executive VP at Aligos Therapeutics, Inc. since 2018.
Formerly, Dr. Symons was Vice President-Disease Area Research & Development at Alios BioPharma, Inc. from 2015 to 2018.
Education includes a doctorate from York University and an undergraduate degree from the University of Central Lancashire.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ALIGOS THERAPEUTICS, INC. 0.64%	2026-03-30	35,112 ( 0.64% )	205 756 $	2026-08-30

Julian Symons active positions

Companies	Position	Start
ALIGOS THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	2018-04-30

All active positions of Julian Symons

Former positions of Julian Symons

Companies	Position	End
Alios BioPharma, Inc. Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases	Corporate Officer/Principal	2018-03-31

See the detail of Julian Symons's experience

Training of Julian Symons

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Julian Symons's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Alios BioPharma, Inc. Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases	Health Technology
York University York University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Central Lancashire University of Central Lancashire Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Aligos Therapeutics, Inc. Aligos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted, curative therapies for hepatologic diseases and viral infections	Health Technology